HTA - 17/34/01

A parallel group, double-blind, randomised, placebo-controlled trial comparing the effectiveness and cost-consequence and cost effectiveness of low dose oral modified release morphine (MRM) versus placebo on the intensity of worst breathlessness in people with chronic breathlessness.

Project title: A parallel group, double-blind, randomised, placebo-controlled trial comparing the effectiveness and cost-consequence and cost effectiveness of low dose oral modified release morphine (MRM) versus placebo on the intensity of worst breathlessness in people with chronic breathlessness.

Call to action: 17/34 17/34 Opioids for the treatment of breathlessness in palliative care

Research type: Primary Research

Chief investigator: Professor Marie Fallon

Contractor: Hull University Teaching Hospitals NHS Trust

Cost: £1,431,239.05

Co-investigators: Dr Adam Wagner, Dr Deans Buchanan, Dr Jeremy Keen, Dr Julie Seymour, Dr Mark Pearson, Dr Nazia Chaudhuri, Dr Peter Hall, Dr Sabrina Bajwah, Dr Simon Hart, Professor David Currow, Professor Irene Higginson, Professor John Norrie.

Started: March 2019 | Status: Research in progress

ISRCTN: 87329095

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.